Literature DB >> 29025273

Higher frequencies of circulating ICOS+, IL-21+ T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy.

Zhihui Zhang1,2, Yunpeng Shi1, Kunmeng Yang1,3, Rebecca Crew4, Haifeng Wang1, Yanfang Jiang1,5,6.   

Abstract

BACKGROUND: T follicular helper (TFH) cells and B cells are known to regulate humoral immune responses. This study is aimed at examining the putative contribution of different subsets of circulating of TFH cells and B cells to membranous nephropathy (MN).
METHODS: A total of 45 MN patients and 19 healthy controls (HCs) were examined for the number of TFH cells and B cells by flow cytometry. The level of 24-h urinary protein and eGFR were calculated, and the level of serum cytokines was examined. The potential association among these measures was analyzed.
RESULTS: Compared to the HCs, MN patients had significantly higher numbers of circulating CD4+CXCR5+, CD4+CXCR5+ICOS+, CD4+CXCR5+CD154+, CD4+CXCR5+IL-21+, and CD4+CXCR5+CD28+ TFH cells, as well as IgD+CD27-CD19+ and CD138+CD19+ B cells. However, the number of IgD+CD27+CD19+ B cells was significantly lower in MN patients than in the HC. The levels of serum IL-21, IL-2, IL-4, IL-10, IL-17A, and IFN-γ were significantly higher in MN patients than in the HC. Furthermore, the numbers of CD4+CXCR5+, CD4+CXCR5+ICOS+, CD4+CXCR5+CD154+, CD4+CXCR5+IL-21+, CD4+CXCR5+CD28+ TFH cells, CD138+CD19+ B cells, and the level of sera IL-21 were negatively correlated with the values of eGFR, but positively correlated with the levels of 24-h urinary proteins. Following treatment, the numbers of CD4+CXCR5+, CD4+CXCR5+ICOS+, CD4+CXCR5+CD154+, CD4+CXCR5+IL-21+, CD4+CXCR5+CD28+ TFH cells, CD138+CD19+ B cells, and the levels of IL-21 were significantly reduced. In contrast, IL-4 and IL-10 levels were noticeably increased after treatment.
CONCLUSIONS: Data suggest that activated TFH and plasma cells may contribute to the pathogenesis of MN.

Entities:  

Keywords:  B cells; TFH cells; membranous nephropathy

Mesh:

Substances:

Year:  2017        PMID: 29025273     DOI: 10.1080/08916934.2017.1385775

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  6 in total

Review 1.  Membranous nephropathy: new pathogenic mechanisms and their clinical implications.

Authors:  Elion Hoxha; Linda Reinhard; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2022-04-28       Impact factor: 42.439

2.  Calcineurin B1 subunit in human peripheral blood mononuclear cells and its role in idiopathic membranous nephropathy.

Authors:  Ying Zhu; Min Zhang; Fan Wang; Jing Sun; Jianda Lu; Ruiying Chen; Qionghong Xie; Jun Xue; Chuanming Hao; Shanyan Lin
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A.

Authors:  Ran Luo; Yichun Cheng; Dan Chang; Tingting Liu; Liu Liu; Guangchang Pei; Nanhui Zhang; Zufeng Wang; Kanglin Guo; Wei Chen; Ming Li; Li Fan; Chunxiu Zhang; Yueqiang Li; Wei Dai; Meiying Zuo; Yulin Xu; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy.

Authors:  Jie Hou; Manli Zhang; Yuhong Ding; Xinrui Wang; Tao Li; Pujun Gao; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2018-06-21       Impact factor: 4.711

Review 5.  Helper T Cells in Idiopathic Membranous Nephropathy.

Authors:  Qihan Zhao; Haoran Dai; Xianli Liu; Hanxue Jiang; Wenbin Liu; Zhendong Feng; Na Zhang; Yu Gao; Zhaocheng Dong; Xiaoshan Zhou; Jieli Du; Naiqian Zhang; Hongliang Rui; Li Yuan; Baoli Liu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

Review 6.  B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management.

Authors:  Benjamin Y F So; Desmond Y H Yap; Tak Mao Chan
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.